Principal Financial Group Inc. Decreases Position in LivaNova PLC (NASDAQ:LIVN)

Principal Financial Group Inc. reduced its stake in LivaNova PLC (NASDAQ:LIVN) by 19.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 171,402 shares of the company’s stock after selling 41,335 shares during the period. Principal Financial Group Inc.’s holdings in LivaNova were worth $9,005,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its position in shares of LivaNova by 97.1% in the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock valued at $37,000 after buying an additional 332 shares during the last quarter. Hexagon Capital Partners LLC increased its position in shares of LivaNova by 117.8% during the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after purchasing an additional 370 shares in the last quarter. Lazard Asset Management LLC purchased a new stake in shares of LivaNova in the 1st quarter valued at about $84,000. Canada Pension Plan Investment Board acquired a new stake in shares of LivaNova in the 2nd quarter valued at about $88,000. Finally, Acadian Asset Management LLC acquired a new stake in shares of LivaNova in the 1st quarter valued at about $94,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Mizuho reduced their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Stifel Nicolaus upped their price target on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Robert W. Baird raised their price objective on shares of LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a research report on Thursday, October 31st. Baird R W upgraded shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, The Goldman Sachs Group started coverage on shares of LivaNova in a research note on Friday, October 4th. They set a “buy” rating and a $65.00 target price for the company. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, LivaNova presently has an average rating of “Buy” and an average price target of $69.17.

LivaNova Trading Up 0.8 %

NASDAQ LIVN opened at $52.53 on Tuesday. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $2.85 billion, a P/E ratio of 125.05 and a beta of 1.01. LivaNova PLC has a 52-week low of $42.75 and a 52-week high of $64.47. The firm has a 50-day moving average price of $51.77 and a 200 day moving average price of $52.86.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.